Clinical Trials on Extensive-stage Small Cell Lung Cancer in Netherlands
Total 419 results
-
Bristol-Myers SquibbRecruitingExtensive-stage Small Cell Lung CancerNetherlands, Belgium, United States, Australia, Greece, Italy, Canada, Japan, Poland, Romania, Spain
-
AmgenRecruitingExtensive Stage Small Cell Lung CancerKorea, Republic of, United States, Netherlands, Taiwan, Switzerland, Spain, Canada, Israel, Germany, France, Belgium, Australia, Japan, Italy, Denmark
-
Amsterdam UMC, location VUmcBoehringer IngelheimRecruitingAdvanced Stage Non-small Cell Lung CancerNetherlands
-
Maastricht Radiation OncologyCompletedStage I-III Non-small Cell Lung CancerNetherlands
-
Radboud University Medical CenterTerminatedStage III Non-small Cell Lung Cancer | Individualized Radiation Dose EscalationNetherlands
-
Maastricht Radiation OncologyCompletedStage I-III Small Cell Lung CancerNetherlands
-
UMC UtrechtUnknown
-
Maastricht Radiation OncologyCompletedNon-small Cell Lung Cancer | Stage IV (Oligo-metastases)Netherlands
-
Maastricht Radiation OncologyUniversity Medical Center Groningen; The Netherlands Cancer InstituteCompletedNon Small Cell Lung Cancer (NSCLC) | Stage III Non-Small Cell Lung Cancer | Radical TreatmentNetherlands
-
University Hospital, EssenRecruitingNSCLC, Stage I | NSCLC Stage II | NSCLC, Stage IIIABelgium, Germany, Netherlands
-
Leiden University Medical CenterJessa Hospital; The Netherlands Cancer InstituteRecruitingImmunotherapy | Non Small Cell Lung Cancer Stage IIINetherlands, Belgium
-
Maastricht Radiation OncologyMaastricht University Medical Center; Zuyderland Medical CentreCompleted
-
Radboud University Medical CenterUMC Utrecht; Amsterdam UMC, location VUmc; St. Antonius Hospital; Dijklander Ziekenhuis and other collaboratorsRecruitingStage III Non-small Cell Lung CancerNetherlands
-
NovaRx CorporationCompletedLung Neoplasm | Carcinoma Non-small Cell Lung Cancer Stage IIIA | Carcinoma Non-small Cell Lung Cancer Stage IIIB | Carcinoma Non-small Cell Lung Cancer Stage IVUnited States, Hungary, United Kingdom, Netherlands, Canada, India, Poland, Serbia
-
Maastricht Radiation OncologyCompletedNon-small Cell Lung CancerNetherlands
-
ETOP IBCSG Partners FoundationAstraZenecaRecruitingImmunotherapy, Chemotherapy, Radiotherapy and Surgery for Synchronous Oligo-metastatic NSCLC (CHESS)Non-small Cell Lung Cancer | Oligometastasis | Stage IVSwitzerland, Netherlands, Spain, Italy
-
Maastricht Radiation OncologyCompleted
-
Maastricht Radiation OncologyCompleted
-
Radboud University Medical CenterAstraZenecaCompletedNon-small Cell Lung CancerNetherlands
-
Radboud University Medical CenterMerck KGaA, Darmstadt, GermanyCompletedNon Small Cell Lung CancerNetherlands
-
The Netherlands Cancer InstituteCompletedInoperable Locally Advanced Non Small Cell Lung CancerNetherlands
-
ETOP IBCSG Partners FoundationBristol-Myers Squibb; Frontier Science Foundation, HellasCompletedNon-small Cell Lung Cancer Stage IIISwitzerland, Netherlands, Spain, Belgium, Germany
-
Maastricht Radiation OncologyWithdrawn
-
Maastricht Radiation OncologyCompleted
-
Maastricht Radiation OncologyAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Maastro...Completed
-
Maastricht Radiation OncologyMerck Sharp & Dohme LLC; Academisch Ziekenhuis MaastrichtCompleted
-
Maastricht Radiation OncologyUniversity of PennsylvaniaCompletedNon Small Cell Lung CancerNetherlands
-
Frame Pharmaceuticals B.V.University Medical Center Groningen; Erasmus Medical Center; The Netherlands... and other collaboratorsNot yet recruiting
-
Amsterdam UMC, location VUmcMerck Sharp & Dohme LLCUnknownNon Small Cell Lung CancerNetherlands
-
University Medical Center GroningenRecruitingNon Small Cell Lung Cancer MetastaticNetherlands
-
Synta Pharmaceuticals Corp.TerminatedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IV | Non-Small-Cell Lung AdenocarcinomaUnited States, France, Spain, Netherlands, Czech Republic, Serbia, Romania, Germany, Belgium, Italy, Hungary, United Kingdom, Canada, Poland, Bosnia and Herzegovina, Austria, Slovenia, Croatia, Russian Federation, Ukraine
-
Merck KGaA, Darmstadt, GermanyCompletedLung Cancer | Non Small Cell Lung CancerNetherlands
-
Maastricht Radiation OncologyAnticancer Fund, Belgium; Reliable Cancer TherapiesTerminatedNon Small Cell Lung Cancer (NSCLC)Netherlands
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerNetherlands
-
Maastricht Radiation OncologyCompletedNon-small Cell Lung CancerNetherlands
-
Erasmus Medical CenterRecruiting
-
Erasmus Medical CenterRecruitingNon-small Cell Lung CancerNetherlands
-
Genentech, Inc.CompletedNon-Squamous Non-Small Cell Lung Cancer, Solid CancersUnited States, Netherlands
-
Radboud University Medical CenterCompletedNSCLC | Locally Advanced Non-Small Cell Lung CancerNetherlands
-
ETOP IBCSG Partners FoundationBristol-Myers Squibb; Intergroupe Francophone de Cancerologie Thoracique; Frontier... and other collaboratorsUnknownSmall Cell Lung Cancer | Limited Stage Small Cell Lung CancerSwitzerland, France, Spain, Germany, United Kingdom, Netherlands, Australia, Belgium
-
Academisch Ziekenhuis MaastrichtThe Netherlands Cancer Institute; ZonMw: The Netherlands Organisation for Health...Completed
-
Maastricht University Medical CenterRecruitingNon-small Cell Lung CancerNetherlands
-
Erasmus Medical CenterRecruitingNon Small Cell Lung Cancer | Liquid Biopsy | Tyrosine Kinase InhibitorNetherlands
-
Academisch Medisch Centrum - Universiteit van Amsterdam...UnknownNon Small Cell Lung Cancer (NSCLC) | Intrathoracic Nodal StagingNetherlands, Poland
-
Maastricht Radiation OncologyMaastricht University Medical Center; The Netherlands Cancer Institute; Zuyderland...CompletedNon-Small Cell Carcinoma of Lung, TNM Stage 4Netherlands
-
BayerCompletedHealthy Volunteers | Advanced Non-small Cell Lung Cancer | EGFR Mutation | HER2 MutationNetherlands
-
Maastricht Radiation OncologyUniversitaire Ziekenhuizen KU LeuvenCompletedNon Small Cell Lung CancerNetherlands, Belgium
-
Galvanize Therapeutics, Inc.Active, not recruitingNon Small Cell Lung CancerHong Kong, Spain, Netherlands
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerNetherlands, United Kingdom
-
Commissie Voor Klinisch Toegepast OnderzoekUnknownLung CancerNetherlands